{"title":"在成人肺模型中,通过在传统机械通气基础上叠加在线肺内冲击通气输送阿布特罗。","authors":"Takashi Karashima, Yuka Mimura-Kimura, Yusuke Mimura","doi":"10.4187/respcare.11249","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Intrapulmonary percussive ventilation (IPV) is frequently used for airway clearance, together with delivery of aerosolized medications. Drug delivery via IPV alone increases with decreasing percussion frequency and correlates with tidal volume ([Formula: see text]), whereas drug delivery via IPV during invasive ventilation is not well characterized. We hypothesized that drug delivery via IPV-invasive ventilation would differ from IPV alone due to control of ventilation by invasive ventilation.</p><p><strong>Methods: </strong>An adult ventilator circuit was used for IPV-invasive ventilation. A normal or a diseased lung model was configured to airway resistance of 5 cm H<sub>2</sub>O/L/s and lung compliance of 100 mL/cm H<sub>2</sub>O or to airway resistance of 20 cm H<sub>2</sub>O/L/s and lung compliance of 50 mL/cm H<sub>2</sub>O, respectively. The ventilator settings were the following: pressure control continuous mandatory ventilation mode, 10 breaths/min; PEEP, 5 cm H<sub>2</sub>O; [Formula: see text], 0.21; inspiratory time, 1 s; no bias flow; and inspiratory pressure, 10 or 15 cm H<sub>2</sub>O for the normal or the diseased lung model, respectively, to reach [Formula: see text] 500 mL with IPV off. Albuterol nebulized from an IPV device was captured in a filter placed before the lung model and quantitated by spectrophotometry.</p><p><strong>Results: </strong>The maximum efficiency of albuterol delivery via IPV-invasive ventilation was not different from that via IPV alone (mean ± SD of loading dose, 3.7 ± 0.2% vs 4.2 ± 0.3%, respectively; <i>P</i> = .12). The mean ± SD albuterol delivery efficiency with IPV-invasive ventilation was lower for the diseased lung model versus the normal model (1.6 ± 0.3% vs 3.2 ± 0.5%; <i>P</i> < .001), which increased with decreasing percussion frequency. In contrast, the mean ± SD [Formula: see text] was lower for the normal lung model versus the diseased model (401 ± 14 mL vs 470 ± 11 mL; <i>P</i> < .001).</p><p><strong>Conclusions: </strong>Albuterol delivery via IPV-invasive ventilation was modulated by percussion frequency but was not increased with increasing [Formula: see text]. The delivery efficiency was not sufficiently high for clinical use, in part due to nebulizer retention and extrapulmonary deposition.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"1092-1099"},"PeriodicalIF":2.4000,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11349587/pdf/","citationCount":"0","resultStr":"{\"title\":\"Albuterol Delivery via In-Line Intrapulmonary Percussive Ventilation Superimposed on Invasive Ventilation in an Adult Lung Model.\",\"authors\":\"Takashi Karashima, Yuka Mimura-Kimura, Yusuke Mimura\",\"doi\":\"10.4187/respcare.11249\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Intrapulmonary percussive ventilation (IPV) is frequently used for airway clearance, together with delivery of aerosolized medications. Drug delivery via IPV alone increases with decreasing percussion frequency and correlates with tidal volume ([Formula: see text]), whereas drug delivery via IPV during invasive ventilation is not well characterized. We hypothesized that drug delivery via IPV-invasive ventilation would differ from IPV alone due to control of ventilation by invasive ventilation.</p><p><strong>Methods: </strong>An adult ventilator circuit was used for IPV-invasive ventilation. A normal or a diseased lung model was configured to airway resistance of 5 cm H<sub>2</sub>O/L/s and lung compliance of 100 mL/cm H<sub>2</sub>O or to airway resistance of 20 cm H<sub>2</sub>O/L/s and lung compliance of 50 mL/cm H<sub>2</sub>O, respectively. The ventilator settings were the following: pressure control continuous mandatory ventilation mode, 10 breaths/min; PEEP, 5 cm H<sub>2</sub>O; [Formula: see text], 0.21; inspiratory time, 1 s; no bias flow; and inspiratory pressure, 10 or 15 cm H<sub>2</sub>O for the normal or the diseased lung model, respectively, to reach [Formula: see text] 500 mL with IPV off. Albuterol nebulized from an IPV device was captured in a filter placed before the lung model and quantitated by spectrophotometry.</p><p><strong>Results: </strong>The maximum efficiency of albuterol delivery via IPV-invasive ventilation was not different from that via IPV alone (mean ± SD of loading dose, 3.7 ± 0.2% vs 4.2 ± 0.3%, respectively; <i>P</i> = .12). The mean ± SD albuterol delivery efficiency with IPV-invasive ventilation was lower for the diseased lung model versus the normal model (1.6 ± 0.3% vs 3.2 ± 0.5%; <i>P</i> < .001), which increased with decreasing percussion frequency. In contrast, the mean ± SD [Formula: see text] was lower for the normal lung model versus the diseased model (401 ± 14 mL vs 470 ± 11 mL; <i>P</i> < .001).</p><p><strong>Conclusions: </strong>Albuterol delivery via IPV-invasive ventilation was modulated by percussion frequency but was not increased with increasing [Formula: see text]. The delivery efficiency was not sufficiently high for clinical use, in part due to nebulizer retention and extrapulmonary deposition.</p>\",\"PeriodicalId\":21125,\"journal\":{\"name\":\"Respiratory care\",\"volume\":\" \",\"pages\":\"1092-1099\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-08-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11349587/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4187/respcare.11249\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4187/respcare.11249","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
背景:肺内冲击通气(IPV)经常用于清除气道,同时输送含有药物的气溶胶。单独通过 IPV 给药会随着叩击频率的降低而增加,并与潮气量(VT)相关,而在传统机械通气(IPV/CMV)过程中通过 IPV 给药的特点尚不明确。我们假设,由于 CMV 对通气的控制,通过 IPV/CMV 给药的情况与单独通过 IPV 给药的情况不同。方法:使用成人呼吸机回路进行 IPV/CMV。正常或病变肺模型分别配置为气道阻力(Raw)5 cm H2O/L/s,肺顺应性(CL)100 mL/cm H2O 或 Raw 20 cm H2O/L/s,CL 50 mL/cm H2O。呼吸机设置为:压力控制持续强制通气模式,10 次/分钟,PEEP 5 cm H2O,FIO2 0.21,吸气时间 1 秒,无偏压流量,正常肺模型或病变肺模型的吸气压力分别为 10 或 15 cm H2O,以在 IPV 关闭时达到 VT 500 mL。从 Phasitron 5 中雾化的阿布特罗被放置在肺模型前的过滤器中捕获,并通过分光光度法进行定量。结果:通过 IPV/CMV 给药的阿布特罗最大效率与仅通过 IPV 给药的效率没有差异(3.7 ± 0.2% vs 4.2 ± 0.3%,平均值 ± 负荷剂量的 SD,P= 0.12)。病肺模型使用 IPV/CMV 的阿布特罗给药效率低于正常模型(1.6 ± 0.3% vs 3.2 ± 0.5%,平均 ± SD,P < .001),且随着叩诊频率的降低而增加。相比之下,正常肺模型的 VT 低于病变肺模型(401 ± 14 mL vs 470 ± 11 mL,平均 ± SD,P < .001)。结论通过 IPV/CMV 输送的阿布特罗受叩诊频率的调节,但不随 VT 的增加而增加。输送效率不够高,无法用于临床,部分原因是雾化器滞留和肺外沉积。
Albuterol Delivery via In-Line Intrapulmonary Percussive Ventilation Superimposed on Invasive Ventilation in an Adult Lung Model.
Background: Intrapulmonary percussive ventilation (IPV) is frequently used for airway clearance, together with delivery of aerosolized medications. Drug delivery via IPV alone increases with decreasing percussion frequency and correlates with tidal volume ([Formula: see text]), whereas drug delivery via IPV during invasive ventilation is not well characterized. We hypothesized that drug delivery via IPV-invasive ventilation would differ from IPV alone due to control of ventilation by invasive ventilation.
Methods: An adult ventilator circuit was used for IPV-invasive ventilation. A normal or a diseased lung model was configured to airway resistance of 5 cm H2O/L/s and lung compliance of 100 mL/cm H2O or to airway resistance of 20 cm H2O/L/s and lung compliance of 50 mL/cm H2O, respectively. The ventilator settings were the following: pressure control continuous mandatory ventilation mode, 10 breaths/min; PEEP, 5 cm H2O; [Formula: see text], 0.21; inspiratory time, 1 s; no bias flow; and inspiratory pressure, 10 or 15 cm H2O for the normal or the diseased lung model, respectively, to reach [Formula: see text] 500 mL with IPV off. Albuterol nebulized from an IPV device was captured in a filter placed before the lung model and quantitated by spectrophotometry.
Results: The maximum efficiency of albuterol delivery via IPV-invasive ventilation was not different from that via IPV alone (mean ± SD of loading dose, 3.7 ± 0.2% vs 4.2 ± 0.3%, respectively; P = .12). The mean ± SD albuterol delivery efficiency with IPV-invasive ventilation was lower for the diseased lung model versus the normal model (1.6 ± 0.3% vs 3.2 ± 0.5%; P < .001), which increased with decreasing percussion frequency. In contrast, the mean ± SD [Formula: see text] was lower for the normal lung model versus the diseased model (401 ± 14 mL vs 470 ± 11 mL; P < .001).
Conclusions: Albuterol delivery via IPV-invasive ventilation was modulated by percussion frequency but was not increased with increasing [Formula: see text]. The delivery efficiency was not sufficiently high for clinical use, in part due to nebulizer retention and extrapulmonary deposition.
期刊介绍:
RESPIRATORY CARE is the official monthly science journal of the American Association for Respiratory Care. It is indexed in PubMed and included in ISI''s Web of Science.